Mario Gabelli Elanco Animal Health Inc Transaction History

Gamco Investors, Inc. Et Al

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$27.74 - $34.09 $394,934 - $485,339	-14,237 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$29.2 - $36.72 $49,494 - $62,240	1,695 Added 13.51%	14,237 $454,000
Q2 2021 Aug 13, 2021	SELL	$28.76 - $35.98 $60,683 - $75,917	-2,110 Reduced 14.4%	12,542 $435,000
Q1 2021 May 14, 2021	SELL	$27.85 - $34.49 $61,270 - $75,878	-2,200 Reduced 13.05%	14,652 $432,000
Q4 2020 Feb 05, 2021	BUY	$27.53 - $33.79 $463,935 - $569,429	16,852 New	16,852 $517,000

437

473M

4.62M

753K

Ticker ELAN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 474,113,984
Market Cap $5.63B
Description
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...

Get notified when there are updates to the investment portfolio of Gamco Investors, Inc. Et Al, based on Form 13F filings with the SEC.

Stay updated on Gamco Investors, Inc. Et Al and Mario Gabelli with notifications on news.